Institute of Internal Medicine and Metabolic Diseases, Federico II University, Naples, Italy Institute of Pharmacology and Toxicology, 2nd University of Naples, Naples, Italy
Riferimenti:
Reader, Bauer, Doyle, The Australian Therapeutic Trial in Mild Hypertension (1980) Lancet, 1, pp. 1261-127
Assmann, The Prospective Cardiovascular Münster (PROCAM) Study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease (1988) Am Heart J, 116, pp. 1713-1724
Stamler, Westworth, Neaton, Factor Intervention Trial Research Group: Is the relation between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? (1986) Findings in 356222 primary screenes of the Multiple Risk Factor Intervention Trial (MRFIT), 256, pp. 2823-2828. , ed 2, JAMA
Laurenzi, Mancini, Menotti, Multiple risk factors in hypertension Results from the Gubbio study (1990) Journal of Hypertension, 8, pp. S7-S12. , suppl 1
Reaven, Role of insulin resistance in human disease (1988) Diabetes, 37, pp. 1595-1607
Ferrannini, Metabolic abnormalities of hypertension (1991) A lesson in complexity, 18, pp. 636-639. , ed 2, Hypertension
Borensztajn, (1987) Lipoprotein Lipase, , Evener, Chicago, IL
Foster, Insulin resistance—A secret killer? (1989) N Engl J Med, 320, pp. 733-734
Slater, Insulin resistance and hypertension (1991) Hypertension, 18, pp. I108-I114. , (suppl)
Pollare, Vessby, Lithell, Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity (1991) Arterioscler Thromb, 11, pp. 1192-1203
Sacks, Dzau, Adrenergic effects on plasma lipoprotein metabolism: Speculation on mechanism of action (1986) Am J Med, 80, pp. 71-81. , suppl 2A
Weidmann, Uehlinger, Gerber, Antihypertensive treatment and serum lipoproteins (1985) J Hypertens, 3, pp. 297-306
Rössner, Studies on an intravenous fat tolerance test (1974) Methodological, experimental and clinical experience with Intralipid, pp. 1-24. , ed 2, Acta Med Scand, [Suppl 564]
Hyelm, Enzymatic determination of hexoses in blood and urine (1966) Scand J Invest, 18, pp. 85-98. , Suppl 192
Siedel, Schlumberger, Klose, Improved reagent for enzymatic determination of serum cholesterol (1981) J Clin Chem Clin Biochem, 19, pp. 838-839
Wahlefeld, Triglycerides determination after enzymatic hydrolysis (1974) Methods of Enzymatic Analysis, 4, pp. 1831-1974. , ed 2, HU Bergemeyer, Academic, New York, NY
Kostner, Enzymatic determination of cholesterol in high density lipoprotein fractions prepared by polyanion precipitation (1976) Clin Chem, 22, pp. 695-698
De Lalla, Gofman, Ultracentrifugal analysis for plasma lipoproteins (1954) Methods of Biochemical Analysis, 1, pp. 459-478. , ed 2, P Glick, Interscience, New York, NY
Marcovina, Di Cola, Rapetto, Development of a radial immunodiffusion technique employing monoclonal antibodies for apoprotein B determination in human plasma (1985) Clin Chim Acta, 147, pp. 117-125
Debuquois, Aurbach, Use of polyethylene glycol to separate free and antibody bound peptide hormones in radioimmunoassay (1971) J Clin Endocrinol Metab, 33, pp. 732-738
Nilsson-Ehle, Measurements of lipoprotein lipase activity (1987) Lipoprotein Lipase, pp. 59-77. , J Borensztajn, Evener, Chicago, IL
Foti, Kimura, De Quattro, Liquid-chromatographic measurement of catecholamines in plasma and urine (1987) Clin Chem, 33, pp. 2209-2213
Coats, Doppler ultrasonic measurement of cardiac output: Reproducibility and validation (1990) Eur Heart J, 11, pp. 49-66. , suppl 1
Nie, Hull, Jenkins, (1975) Statistical Package for Social Sciences, , ed 2, McGraw-Hill, New York, NY
Patsch, Prasad, Gotto, Jr, High density lipoprotein2 (1987) Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase, 80, pp. 341-347. , ed 2, J Clin Invest
Levy, Deckelbaum, Thibault, In vitro remodelling of plasma lipoproteins in whole plasma by lipoprotein lipase in primary and secondary hypertriglyceridaemia (1990) Eur J Clin Invest, 20, pp. 422-431
Marotta, Ferrara, Pasanisi, Enhancement of exogenous triglyceride removal following calcium channel blockade (1989) Artery, 16, pp. 312-326
Eckel, Lipoprotein lipase (1989) A multifunctional enzyme relevant to common metabolic diseases, 320, pp. 1060-1068. , ed 2, N Engl J Med
Ashby, Bennett, Spencer, Post-translational regulation of lipoprotein lipase activity in adipose tissue (1978) Biochem J, 176, pp. 865-872
Farese, Yost, Eckel, Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans (1991) Metabolism, 40, pp. 214-216
Zavaroni, Bonora, Pagliara, Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance (1989) N Engl J Med, 320, pp. 702-706
Zavaroni, Dall'Aglio, Alpi, Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride (1985) Atherosclerosis, 55, pp. 259-266
Stalder, Pometta, Suenram, Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men (1981) Diabetologia, 21, pp. 544-548
Capaldo, Rivellese, Santoro, Relationship between insulin response to intravenous glucose and plasma lipoproteins in healthy men (1985) Artery, 13, pp. 108-126
Laakso, How good a marker is insulin level for insulin resistance? (1993) Am J Epidemiol, 137, pp. 959-965
Frayn, Insulin resistance and lipid metabolism (1993) Curr Opin Lipidol, 4, pp. 197-204
Miesenböck, Patsch, Postprandial hyperlipidemia The search for the atherogenic lipoprotein (1992) Current Opinion in Lipidology, 3, pp. 196-201
Taskinen, Kuusi, Helve, Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes (1988) Arteriosclerosis, 8, pp. 168-177
Tuck, Obesity, the sympathetic nervous system, and essential hypertension (1992) Hypertension, 19, pp. I67-I77. , (suppl)
Mathias, Role of sympathetic efferent nerves in blood pressure regulation and in hypertension (1991) Hypertension, 18, pp. 22-30. , suppl 3
Rowe, Young, Minaker, Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man (1981) Diabetes, 30, pp. 219-225
Ferrara, Di Marino, Russo, Doxazosin and captopril in mildly hypercholesterolemic hypertensive patients (1993) The Doxazosin-Captopril in Hypercholesterolemic Hypertensives Study, 21, pp. 97-104. , ed 2, Hypertension
Medical Research Council Working Party, MRC trial of treatment of mild hypertension Principal results (1985) BMJ, 291, pp. 97-104
Mancini, Ferrara, Strazzullo, Metabolic disturbances and antihypertensive therapy (1991) J Hypertens, 9, pp. S47-S50. , suppl 3
Maling, Ferrara, Mucklow, Blood pressure and plasma noradrenaline during single high-dose beta adrenoceptor blockade (1979) Eur J Clin Pharmacol, 15, pp. 375-379
Day, Metcalfe, Simpson, Adrenergic mechanism in control of plasma lipid concentrations (1982) Br Med J, 284, pp. 1145-1148
Murphy, Sugrue, Trayner, Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease (1984) Br Heart J, 51, pp. 589-594
R ssner, Studies on an intravenous fat tolerance test (1974) Methodological, experimental and clinical experience with Intralipid, pp. 1-24. , ed 2, Acta Med Scand, [Suppl 564]
Miesenb ck, Patsch, Postprandial hyperlipidemia The search for the atherogenic lipoprotein (1992) Current Opinion in Lipidology, 3, pp. 196-201
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(105 visite) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 DettagliEsporta in BibTeXEsporta in EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(143 visite) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 DettagliEsporta in BibTeXEsporta in EndNote
Testino G, Leone S, Fagoonee S, Del Bas JM, Rodriguez B, Puiggros F, Marine S, Rodriguez MA, Morina D, Armengol L, Caimari A, Arola L, Cimini FA, Barchetta I, Carotti S, Bertoccini L, Baroni MG, Vespasiani-gentilucci U, Cavallo MG, Morini S, Nelson JE, Roth CL, Wilson LA, Yates KP, Aouizerat B, Morgan-stevenson V, Whalen E, Hoofnagle A, Mason M, Gersuk V, Yeh MM, Kowdley KV, Lee SM, Jun DW, Cho YK, Jang KS, Kucukazman M, Ata N, Dal K, Yeniova AO, Kefeli A, Basyigit S, Aktas B, Akin KO, Agladioglu K, Ure OS, Topal F, Nazligul Y, Beyan E, Ertugrul DT, Catena C, Cosma C, Camozzi V, Plebani M, Ermani M, Sechi LA, Fallo F, Goto Y, Ray MB, Mendenhall CL, French SW, Gartside PS Serum vitamin A deficiency and increased intrahepatic expression of cytokeratin antigen in alcoholic liver disease(6 visite) Hepatology (ISSN: 1827-1669electronic, 0026-4806linking), 1988 Sep; 83120693611123109(5): 1019-1026. Impact Factor:0.913 DettagliEsporta in BibTeXEsporta in EndNote
503 Records (352 escludendo Abstract e Conferenze). Impact factor totale: 1661.937 (1136.481 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 1807.587 (1213.362 escludendo Abstract e Conferenze).
ibb.cnr.it
